GLP-1 drugs may impact smell and taste

A study has found that long-term use of GLP-1 medications by patients with type 2 diabetes increases the risk of experiencing smell and taste disorders. The incidence rates rose by 81% for smell and 52% for taste compared to patients using other medications. The results also showed that the actual rates of these sensory disorders were very low, with 0.37% among users and 0.22% among non-users. The researchers emphasized the importance of more precise health monitoring and analyzing the mechanisms behind this relationship.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل